scispace - formally typeset
S

Shelley H. Smith

Researcher at Eli Lilly and Company

Publications -  6
Citations -  256

Shelley H. Smith is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Balanol & Azepane. The author has an hindex of 3, co-authored 6 publications receiving 253 citations. Previous affiliations of Shelley H. Smith include Durham University.

Papers
More filters
Journal ArticleDOI

Total Synthesis of (-)-Balanol

TL;DR: Balanol, a fungal metabolite with potent protein kinase C inhibitory properties, has been prepared in a total synthesis which makes use of anionic homo-Fries rearrangement approach to the benzophenone subunit and in which the azepane subunit is obtained from (2S,3R)-3-hydroxyly- sine.
Journal ArticleDOI

Total Synthesis of (-)- and (+)-Balanol(1).

TL;DR: In this paper, two total syntheses of the potent protein kinase C inhibitory fungal metabolite balanol are described in the first approach, the core aminohydroxyazepane subunit was prepared in racemic form by stereospecific functionalization of N-benzyl-e-caprolactam resolution prior to coupling to the benzophenone subunit provided access to both enantiomers of balanol.
Journal ArticleDOI

Two Chiral Syntheses of threo-3-Hydroxylsine

TL;DR: In this paper, two chiral syntheses of 3-hydroxylysine, a naturally occurring amino acid and a putative intermediate in the synthesis of balanol, a potent protein kinase C inhibitor, are described.
Journal ArticleDOI

Total Synthesis of (-)- and (+)-Balanol.

TL;DR: Two total syntheses of the potent protein kinase C inhibitory fungal metabolite balanol are described, and an efficient silicon-mediated cyclization of (2S,3R)-3-hydroxylysine followed by reduction provided the azepane subunit in enantiomerically pure form.